Compare Brevis (BREV) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Injective — how do they compare? Brevis trades at Rp1,331 (market cap Rp334,02M, Rp229,47M 24h volume), while Injective trades at Rp85,566 (market cap Rp8,48T, Rp1,32T 24h volume). The key difference: Injective is far larger — about 25387.7× Brevis's market cap, and Brevis's supply is capped (250M / 1B BREV (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 6 Days and Injective for 36 Days on average.
| BREV | INJ | |
|---|---|---|
Market Cap | Rp334,02M | Rp8,48T |
Volume (24h) | Rp229,47M | Rp1,32T |
Circulating Supply | 250M / 1B BREV (25%) | 100M INJ |
Typical Hold Time | 6 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) shows mixed technical signals with an overall bullish bias despite bearish moving averages. The token trades at Rp1,345.9 with a market cap of Rp333.86 million and 25% circulating supply. Key technical indicators show RSI_6 at 27.08 (oversold) and strong ADX readings suggesting trending momentum. Support levels are established at Rp1,256-Rp1,335 while resistance sits at Rp1,413-Rp1,492.
Overall outlook suggests cautious optimism with oversold RSI signaling potential rebound. Key opportunities include technical bounce from support levels, while major risks involve limited liquidity (Rp333.86M market cap) and absence of recent protocol updates. Investors should monitor volume confirmation for sustained moves.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
